WashU Medicine researchers have developed an Alzheimer’s blood test symptom prediction model that estimates when individuals may begin to show signs of the disease.
ProSomnus's has received funding to advance its sleep apnoea treatments, which are positioned as an alternative to CPAP.
A key part of the agreement centres on developing point-of-care-ultrasound technologies that are fit for purpose in frontline ...
One of the key proposals the MHRA seeks feedback on is the ‘indefinite recognition’ of EU CE-marked medical devices in the UK.
NG Biotech and Hardy Diagnostics have received the US FDA breakthrough device designation for two rapid diagnostic assays, NG ...
QuidelOrtho has signed a strategic supply agreement with Lifotronic Technology to expand its global immunoassay portfolio.
Portal Diabetes has received the US FDA breakthrough device designation for its implantable insulin pump system, known as the Portal Pump.
Levee Medical has secured over $12m in additional financing to support the PMA process as the ARID II Trial of the Voro Urologic Scaffold progresses.
Despite the growing burden of kidney disease, a complex array of issues in the US and worldwide makes innovation in the space particularly difficult.
Merck and Calla Lily Clinical Care have announced a strategic partnership to advance Callavid, an intravaginal drug delivery platform.
Edwards’ financials reveal that its transcatheter mitral and tricuspid therapies (TMTT) portfolio grew by 56.4% in 2025.
Elumn8 Medical has announced the initial close of its Series C funding and rebrand from Simpson Interventions to Elumn8 Medical.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results